Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ICCC

Immucell Corp.

Nov 28 • 03:16PM ET

4.60

Dollar change -0.07
Percentage change -1.50	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.81	Insider Own	28.46%	Shs Outstand	7.75M	Perf Week	-0.31%
Market Cap	35.65M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	5.54M	Perf Month	-3.36%
Income	-6.30M	PEG	-	EPS next Q	-	Inst Own	13.34%	Short Float / Ratio	0.12% / 0.38	Perf Quarter	-1.08%
Sales	16.29M	P/S	2.19	EPS this Y	-	Inst Trans	-0.86%	Short Interest	0.01M	Perf Half Y	-9.09%
Book/sh	3.33	P/B	1.38	EPS next Y	-	ROA	-13.86%	Target Price	14.00	Perf Year	-27.67%
Cash/sh	0.26	P/C	17.91	EPS next 5Y	-	ROE	-21.73%	52W Range	4.26 - 7.84	Perf YTD	-24.59%
Dividend	-	P/FCF	-	EPS past 5Y	-60.75%	ROI	-15.29%	52W High	-41.33%	Beta	0.60
Dividend %	-	Quick Ratio	1.38	Sales past 5Y	12.79%	Gross Margin	19.84%	52W Low	7.98%	ATR	0.26
Employees	74	Current Ratio	3.59	Sales Q/Q	12.52%	Oper. Margin	-39.16%	RSI (14)	38.93	Volatility	4.69% 5.05%
Optionable	No	Debt/Eq	0.64	EPS Q/Q	-43.38%	Profit Margin	-38.70%	Rel Volume	0.65	Prev Close	4.67
Shortable	Yes	LT Debt/Eq	0.58	Earnings	Nov 13 AMC	Payout	-	Avg Volume	17.15K	Price	4.60
Recom	1.00	SMA20	-8.54%	SMA50	-9.61%	SMA200	-12.00%	Volume	10,138	Change	-1.50%

Nov-15-23 02:04PM	ImmuCell Corporation (NASDAQ:ICCC) Q3 2023 Earnings Call Transcript (Insider Monkey) -5.28%
Nov-13-23 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023 (GlobeNewswire)
Nov-07-23 12:15PM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023 (GlobeNewswire)
Oct-05-23 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023 (GlobeNewswire)
Aug-29-23 08:00AM	ImmuCell Announces Submission of CMC Technical Section to the FDA (GlobeNewswire)
10:16PM	Loading…
Aug-11-23 10:16PM	Q2 2023 ImmuCell Corp Earnings Call (Thomson Reuters StreetEvents)
Aug-10-23 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023 (GlobeNewswire)
Aug-07-23 12:00PM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023 (GlobeNewswire)
Jul-11-23 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2023 (GlobeNewswire)
Jun-28-23 04:05PM	ImmuCell Announces Change in Timing of Anticipated FDA Submission (GlobeNewswire) -10.35%
Jun-21-23 04:05PM	ImmuCell Appoints Bryan K. Gathagan to Board of Directors (GlobeNewswire)
Jun-15-23 04:05PM	ImmuCell Announces Approval of Principal Terms of a $3 Million Debt Facility (GlobeNewswire)
May-16-23 09:00AM	ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders (GlobeNewswire)
May-15-23 07:36AM	There's No Escaping ImmuCell Corporation's (NASDAQ:ICCC) Muted Revenues (Simply Wall St.) +7.11%
May-12-23 09:46PM	Q1 2023 ImmuCell Corp Earnings Call (Thomson Reuters StreetEvents) -6.46%
04:05PM	Loading…
May-11-23 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2023 (GlobeNewswire)
May-04-23 06:30AM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2023 (GlobeNewswire)
Apr-05-23 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2023 (GlobeNewswire)
Feb-23-23 05:26AM	ImmuCell Full Year 2022 Earnings: US$0.32 loss per share (vs US$0.01 loss in FY 2021) (Simply Wall St.)
Feb-21-23 04:05PM	ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2022 (GlobeNewswire)
Feb-15-23 11:55AM	ImmuCell to Announce Unaudited Financial Results for the Year Ended December 31, 2022 (GlobeNewswire)
Jan-09-23 04:05PM	ImmuCell Announces Preliminary, Unaudited Sales Results for the Year Ended December 31, 2022 (GlobeNewswire)
Dec-23-22 10:24PM	ImmuCell Corporation (NASDAQ:ICCC) Q3 2022 Earnings Call Transcript (Insider Monkey)
Nov-21-22 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2022 (GlobeNewswire) -11.27%
Nov-10-22 04:05PM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2022 (GlobeNewswire)
Oct-24-22 06:20AM	Investors in ImmuCell (NASDAQ:ICCC) have made a decent return of 48% over the past three years (Simply Wall St.)
Oct-05-22 06:30AM	ImmuCell Announces Preliminary, Unaudited Sales Results for Third Quarter of 2022 (GlobeNewswire)
Sep-14-22 05:00PM	ImmuCell to Participate in the Lytham Partners Fall 2022 Investor Conference (GlobeNewswire)
Aug-12-22 09:00AM	Edited Transcript of ICCC.OQ earnings conference call or presentation 12-Aug-22 1:00pm GMT (Thomson Reuters StreetEvents) -6.86%
Aug-11-22 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2022 (GlobeNewswire)
09:24AM	Loading…
Aug-05-22 09:24AM	Does ImmuCell (NASDAQ:ICCC) Have A Healthy Balance Sheet? (Simply Wall St.)
Aug-04-22 06:30AM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2022 (GlobeNewswire)
Jul-27-22 08:05PM	ImmuCell Receives Technical Section Incomplete Letter from FDA Pertaining to Re-Tain® (GlobeNewswire)
Jul-07-22 06:30AM	ImmuCell Announces Preliminary, Unaudited Sales Results for Second Quarter of 2022 (GlobeNewswire)
Jun-15-22 03:10PM	Is ImmuCell Corporation's (NASDAQ:ICCC) Stock Price Struggling As A Result Of Its Mixed Financials? (Simply Wall St.)
May-19-22 08:00AM	ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders (GlobeNewswire)
May-16-22 02:12PM	ImmuCell's (NASDAQ:ICCC) investors will be pleased with their respectable 35% return over the last five years (Simply Wall St.)
May-12-22 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2022 (GlobeNewswire)
May-10-22 10:00AM	ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2022 (GlobeNewswire) -8.08%
May-05-22 01:18PM	UPDATE -- Dr. Mark Wustenberg joins ImmuCell as Commercial Leader of Stakeholder Engagement (GlobeNewswire)
11:17AM	Dr. Mark Wustenberg joins ImmuCell as Commercial Leader of Stakeholder Engagement (GlobeNewswire)
Apr-11-22 04:05PM	ImmuCell Announces Record Preliminary, Unaudited Sales Results for First Quarter of 2022 (GlobeNewswire)
Feb-26-22 07:34AM	ImmuCell (NASDAQ:ICCC) Has A Somewhat Strained Balance Sheet (Simply Wall St.)
Feb-22-22 04:05PM	ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2021 (GlobeNewswire)
Feb-16-22 06:30AM	ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2021 (GlobeNewswire)
Jan-05-22 06:30AM	ImmuCell Announces Record Preliminary, Unaudited Sales Results for the Year Ended December 31, 2021 (GlobeNewswire) +10.31%
Nov-15-21 04:05PM	ImmuCell Announces Unaudited Financial Results for the Third Quarter Ended September 30, 2021 (GlobeNewswire)
Nov-09-21 04:00PM	ImmuCell to Announce Unaudited Financial Results for the Third Quarter Ended September 30, 2021 (GlobeNewswire)
Oct-06-21 06:30AM	ImmuCell Announces Record Preliminary, Unaudited Sales Results for Third Quarter of 2021 (GlobeNewswire)
Sep-14-21 06:30AM	Raffael Lichdi, DVM Joins ImmuCells Sales & Marketing Team (GlobeNewswire) +10.17%
Sep-08-21 08:55AM	Is ImmuCell (NASDAQ:ICCC) Weighed On By Its Debt Load? (Simply Wall St.)
Sep-07-21 08:25PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmuCell Corporation - ICCC (ACCESSWIRE)
Sep-02-21 06:42PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmuCell Corporation - ICCC (Newsfile)
Aug-31-21 09:31PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmuCell Corporation - ICCC (GlobeNewswire)
Aug-29-21 06:00PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmuCell Corporation - ICCC (ACCESSWIRE)
Aug-25-21 07:18PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmuCell Corporation - ICCC (Newsfile)
Aug-24-21 07:29PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmuCell Corporation - ICCC (PR Newswire) -6.05%
12:17PM	Mid-Day Market Update: Crude Oil Rises Over 2%; Theravance Biopharma Shares Slide (Benzinga)
06:30AM	ImmuCell Required to Prepare Second Submission of Final Major Technical Section for Re-Tain® (GlobeNewswire)
Aug-12-21 04:05PM	ImmuCell Announces Unaudited Financial Results for the Second Quarter Ended June 30, 2021 (GlobeNewswire)
Aug-05-21 06:30AM	ImmuCell to Announce Unaudited Financial Results for the Second Quarter Ended June 30, 2021 (GlobeNewswire)
Jul-07-21 07:00AM	ImmuCell Announces Strong Preliminary, Unaudited Sales Results for Second Quarter of 2021 (GlobeNewswire)
Jun-10-21 01:55AM	Here's Why ImmuCell Corporation's (NASDAQ:ICCC) CEO May Deserve A Raise (Simply Wall St.) +6.56%
May-19-21 12:00PM	ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders (GlobeNewswire)
May-14-21 07:15AM	ImmuCell Corp. to Host Earnings Call (ACCESSWIRE)
May-13-21 04:05PM	ImmuCell Announces Unaudited Financial Results for the First Quarter Ended March 31, 2021 (GlobeNewswire)
May-06-21 01:41PM	ImmuCell to Announce Unaudited Financial Results for the First Quarter Ended March 31, 2021 (GlobeNewswire)
Apr-19-21 04:53AM	Did You Miss ImmuCell's (NASDAQ:ICCC) Impressive 117% Share Price Gain? (Simply Wall St.) -5.66%
Apr-14-21 05:15PM	ImmuCell Closes $4,250,000 Equity Financing (GlobeNewswire)
Apr-07-21 08:00AM	ImmuCell Announces Preliminary, Unaudited Sales Results for First Quarter of 2021 (GlobeNewswire)
Feb-23-21 07:15AM	ImmuCell Corp. to Host Earnings Call (ACCESSWIRE) -12.01%
Feb-22-21 04:03PM	ImmuCell Makes Important Regulatory Submission and Announces Unaudited Financial Results for the Year Ended December 31, 2020 (GlobeNewswire)
Feb-16-21 01:42PM	ImmuCell to Announce Unaudited Financial Results for the Year Ended December 31, 2020 (GlobeNewswire)
Jan-07-21 08:00AM	ImmuCell Announces Preliminary, Unaudited Sales Results for the Year Ended December 31, 2020 (GlobeNewswire)
Dec-15-20 04:05PM	ImmuCell Announces Restructuring of its Bank Debt (GlobeNewswire)
Nov-12-20 04:05PM	ImmuCell Announces Unaudited Financial Results for the Third Quarter Ended September 30, 2020 (GlobeNewswire)
07:44AM	The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal (Benzinga)
Nov-05-20 02:10PM	ImmuCell to Announce Unaudited Financial Results for Third Quarter of 2020 (GlobeNewswire)
Oct-19-20 12:35PM	How Much Does ImmuCell's (NASDAQ:ICCC) CEO Make? (Simply Wall St.)
Oct-06-20 08:00AM	ImmuCell Announces Preliminary, Unaudited Sales Results for the Quarter Ended September 30, 2020 (GlobeNewswire)
Aug-12-20 04:05PM	ImmuCell Announces Unaudited Financial Results for the Second Quarter Ended June 30, 2020 (GlobeNewswire)
Aug-06-20 08:00AM	ImmuCell to Announce Unaudited Financial Results for Second Quarter of 2020 (GlobeNewswire)
Jul-07-20 08:00AM	ImmuCell Announces Preliminary, Unaudited Sales Results for the Second Quarter Ended June 30, 2020 (GlobeNewswire)
Jun-16-20 08:00AM	ImmuCell Receives $500,000 Loan from the Maine Technology (GlobeNewswire)
May-18-20 11:48AM	Edited Transcript of ICCC earnings conference call or presentation 14-May-20 1:00pm GMT (Thomson Reuters StreetEvents)
May-14-20 01:35PM	ImmuCell Corporation to Present at Lytham Partners Virtual Investor Conference (PR Newswire)
08:42AM	ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders (GlobeNewswire)
May-13-20 04:05PM	ImmuCell Announces Unaudited Financial Results for the First Quarter Ended March 31, 2020 (GlobeNewswire)
May-07-20 12:00PM	ImmuCell to Announce Unaudited Financial Results for First Quarter of 2020 (GlobeNewswire) -6.87%
Apr-20-20 10:52AM	Does ImmuCell Corporation (NASDAQ:ICCC) Have A High Beta? (Simply Wall St.)
Apr-14-20 08:00AM	ImmuCell Receives $938,000 in Support under the Paycheck Protection Program (GlobeNewswire)
Apr-03-20 07:36AM	The Daily Biotech Pulse: Fate Therapeutics Inks Cell Therapy Deal With J&J, Zentalis IPO (Benzinga)
Apr-02-20 04:29PM	ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Quarter Ended March 31, 2020 (GlobeNewswire) -8.99%
Mar-11-20 04:05PM	ImmuCell Announces Refinancing of its Bank Debt (GlobeNewswire)
Mar-01-20 09:09AM	Why ImmuCell Corporation's (NASDAQ:ICCC) CEO Pay Matters To You (Simply Wall St.)
Feb-26-20 01:09AM	Edited Transcript of ICCC earnings conference call or presentation 19-Feb-20 2:00pm GMT (Thomson Reuters StreetEvents)
Feb-19-20 12:35PM	ImmuCell Announces Correction to its Reported Unaudited Loss Per Share from ($0.06) to ($0.04) for the Quarter Ended December 31, 2019 (GlobeNewswire)
Feb-18-20 04:05PM	ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2019 (GlobeNewswire) +5.51%
Feb-13-20 09:17AM	ImmuCell to Announce Preliminary Financial Results for the Year Ended December 31, 2019 (GlobeNewswire)
Jan-24-20 12:04PM	Why I Love Trading A Small Account, And Why You Should Too (Benzinga)

ImmuCell Corp. engages in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kits, and purified nisin intramammary treatment for mastitis. The company was founded in 1982 and is headquartered in Portland, ME.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ICCC

Immucell Corp.

Upgrade your FINVIZ experience